Orthopediatrics (KIDS) Invested Capital (2015 - 2026)

Orthopediatrics' Invested Capital history runs 12 years deep, the most recent figure standing at $445.4 million for Q1 2026.

• In Q1 2026, Invested Capital rose 4.91% year-over-year to $445.4 million; the TTM figure through Mar 2026 stood at $445.4 million (up 4.91% YoY), while the FY2025 annual figure was $452.6 million, up 4.76% from the prior year.
• Invested Capital was $445.4 million for Q1 2026 at Orthopediatrics, down from $452.6 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $458.2 million in Q2 2025 to a low of $216.1 million in Q1 2022.
• Historically, Invested Capital has averaged $390.4 million across 5 years, with a median of $384.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Invested Capital declined 3.24% in 2022, then jumped 73.12% in 2023.
• A 5-year view of Invested Capital shows it stood at $379.6 million in 2022, then advanced by 2.25% to $388.1 million in 2023, then rose by 11.33% to $432.0 million in 2024, then advanced by 4.76% to $452.6 million in 2025, then fell by 1.6% to $445.4 million in 2026.
• The last three Invested Capital figures came in at $445.4 million (Q1 2026), $452.6 million (Q4 2025), and $454.6 million (Q3 2025), per Business Quant data.